OOIR: Observatory of International Research

Papers

(The median citation count of Heart Rhythm is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
EP News: Allied Professionals	228
EP News: Pediatric and Congenital Electrophysiology	160
EP News: Case Reports	155
A novel method for septal reduction therapy by three-dimensional guided transvenous intraseptal pulsed-field ablation	148
Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?	140
Table of Contents	135
Remarkable Reviewers	122
Table of Contents	113
Notable Papers	108
EP News: Basic and Translational	96
EP News: Basic and Translational	92
EP News: Allied Professionals	88
LB-456089-3 WORLD WIDE EXPERIENCE WITH AN END-HOLE IRRIGATED NEEDLE CATHETER FOR ABLATION OF REFRACTORY VENTRICULAR ARRHYTHMIAS: FINAL REPORT	83
EP News: Basic and Translational	76
Late-Breaking Clinical Trials LB-456088: Late-Breaking Clinical Trials and Science - Registry - CIED	75
Long-term clinical outcomes of asymptomatic patients with spontaneous type 1 Brugada electrocardiographic pattern undergoing electrophysiologic study for risk stratification	69
Compliance and complications in catecholaminergic polymorphic ventricular tachycardia	68
Understanding AI bias in clinical practice	67
Balancing innovation and professionalism: The emerging role of AI-powered chatbots in medical consultation	66
Long-term outcomes after catheter ablation for idiopathic atypical atrial flutter	65
Managing data overload: AI, wearables, and apps	63
Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score–matched comparison with direct oral anticoagulant	60
Arrhythmia detection using an implantable loop recorder after a negative electrophysiology study in Brugada syndrome: Observations from a multicenter international registry	59
Regional differences in the outcomes of catheter ablation for ventricular tachycardia in the United States	58
Table of Contents	54

EP News: Clinical	52
EP News: Case Reports	51
PO-02-157 IMPACT OF ATRIAL FIBRILLATION ON QUALITY OF LIFE IN HYPERTROPHIC CARDIOMYOPATHY	49
Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement	49
Outcome of cardiac implantable electronic devices in pediatric heart transplant recipients	49
Cryoballoon pulmonary vein isolation: Double stack vs standard ablation	48
Decisional conflict and defibrillator implantation choices among Black women and men with chronic systolic heart failure	46
Prognostic importance of ischemic heart disease for patients with atrial fibrillation undergoing catheter ablation	45
Traumatic brain injury is associated with the subsequent risk of atrial fibrillation or atrial flutter	44
EP News: Basic and Translational	44
Diagnosis and cure of supraventricular tachycardia	43
To the Editor— Smartwatch determination of atrial fibrillation burden	43
A “hands-on” approach to femoral lead extraction: Indications, tools, and techniques	42
EP News: Basic and Translational	42
Low-voltage potentials contribute to postoperative atrial fibrillation development in obese patients	41
Spatial ventricular gradient is associated with pacing-induced cardiomyopathy	41
In silico pace mapping identifies pacing sites more accurately than inverse body surface potential mapping	41
Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE study	39
Chronic angiotensin-converting enzyme inhibition attenuates frailty and protects against atrial fibrillation in aging mice	39
Supraventricular tachycardia with double trouble	37
EP News: Basic and Translational	36
Stereotactic arrhythmia radioablation (STAR)—A systematic review and meta-analysis of prospective trials on behalf of the STOPSTORM.eu consortium	36
Evaluation of noninvasive isochronal late activation mapping in scar-related ventricular tachycardia with electrocardiographic imaging against contact mapping	35
Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application: DIGITOTAL study	35
Patient-reported symptomatic events do not adequately reflect atrial arrhythmia	33
Spiral wave breakup: Optical mapping in an explanted human heart shows the transition from ventricular tachycardia to ventricular fibrillation and self-termination	32
Stereotactic arrhythmia radioablation: A novel therapy for cardiac arrhythmia	32
Association between nocturnal heart rate variability and incident cardiovascular disease events: The HypnoLaus population-based study	31
B-PO03-170 OUTCOMES OF ATRIAL FIBRILLATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE	31
ID: 4116646 Clinical Validation of the Arrhythmia Detection Functionality in a Single-Lead ECG Chest Strap Device	30
ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection	30
ID: 4122069 Machine Learning Algorithm for QTc Measurement and AAD Dosing Recommendations in Long QT mECG Dataset	30
Anatomy terminology—Note from the Editors	30
ID: 4120879 Deep Learning Approaches For Prediction of Ventricular Arrhythmias Using Upstream Electrograms From Intracardiac Devices	29
ID: 4121781 Enhancing Arrhythmia Diagnosis: A Comparison Between One and Three-Channel ECG Recordings	28
ID: 4116352 Digital versus Conventional Follow-up of Patients after Catheter Ablation of Atrial Fibrillation	28
ID: 4115648 SmartReports™ Software-Assisted Reporting Technology Maximizes CIED Remote Transmission Review Efficiency	28
PO-03-217 SUTURE CLOSURE AFTER VEIN ACCESS FOR CARDIAC PROCEDURES (SAFE-VEIN) TRIAL: A RANDOMIZED, PROSPECTIVE STUDY OF THE SAFETY AND EFFICACY OF PERCLOSE PROGLIDE CLOSURE DEVICE COMPARED WITH A CONV	28
ID: 4115719 Leveraging an Integrated Cardiac Device Data Platform to Monitor Patient Outcomes Before and After Intervention for Atrial Fibrillation	28
PO-05-208 EFFICACY OF LEFT BUNDLE PACING VERSUS BIVENTRICULAR PACING IN CARDIAC RESYNCHRONIZATION THERAPY PATIENTS: SELECT SITE - COHORT STUDY	27
PO-05-181 GLYCOLYTIC PROTEINS ARE DOWNREGULATED IN LEFT ATRIUM OF PATIENTS IN ATRIAL FIBRILLATION	27
Scratching beneath the surface: Revisiting the accuracy of ECG-based prediction algorithms	27
PO-03-245 ATRIAL FIBRILLATION (AF) CAN ADVERSELY IMPACT HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) BY ITS ASSOCIATION WITH HEART FAILURE (HF) PROGRESSION IN EARLY SYMPTOMATIC HF AND PUMP F	27
PO-05-174 HIGH-POWER SHORT-DURATION VERSUS LOW-POWER LONG-DURATION ABLATION FOR PULMONARY VEIN ISOLATION: A SUBSTUDY OF THE AWARE RANDOMIZED CONTROLLED TRIAL	27
PO-03-243 CONTEMPORARY PAROXYSMAL ATRIAL FIBRILLATION ABLATION TRENDS FROM REAL WORLD PRACTICE: INSIGHTS FROM THE LARGE MULTI-CENTER PROSPECTIVE REAL-AF REGISTRY	27
PO-05-205 CLINICAL SIGNIFICANCE OF NEW ONSET ATRIAL FIBRILLATION IN PATIENTS ADMITTED FOR ACUTE CORONARY SYNDROME	26
PO-634-05 RATES AND PREDICTORS OF HOSPITAL AND EMERGENCY DEPARTMENT CARE AFTER CATHETER ABLATION OF ATRIAL FIBRILLATION	25
EP News: Basic and Translational	25
Who is at risk of atrial fibrillation?	25
PO-633-07 RIGHT-SIDED VS. LEFT-SIDED LEFT BUNDLE AREA LEAD IMPLANTS - A SUCCESS STORY?	25

Letter to the Editor—Phone interaction with CIEDs: Problem or not	25
PO-02-064 REDUCED POST-ABLATION CHEST PAIN WITH ACTIVE ESOPHAGEAL COOLING	25
Incessant multiform ectopy in a young woman: What is the mechanism and treatment?	25
PO-635-05 VENTRICULAR ARRHYTHMIA ABLATION WITHOUT FLUOROSCOPIC UTILIZATION - A SINGLE CENTER EXPERIENCE	24
PO-635-02 FACTORS ASSOCIATED WITH INFUSION NEEDLE RADIOFREQUENCY ABLATION FAILURE IN PATIENTS WITH REFRACTORY VENTRICULAR TACHYCARDIA	24
PO-01-103 IMPACT OF FILTERED IMPEDANCE DROP ON ATRIAL LESION SIZE PREDICTION	24
PO-01-012 THE IMPACT OF CEREBRAL MICROBLEEDS ON COGNITIVE DECLINE IN PATIENTS WITH ATRIAL FIBRILLATIO	24
PO-635-01 REDUCTION OF FAR-FIELD POTENTIALS USING CLOSE-UNIPOLAR ELECTROGRAMS IN A NOVEL ULTRA-HIGH RESOLUTION CATHETER MAPPING SYSTEM: EVALUATION IN A SWINE ATRIAL LINEAR LESION MODEL	24
PO-635-08 REDUCTION IN ANTI-ARRHYTHMIC DRUG USE AND IMPROVEMENT IN QUALITY OF LIFE FOLLOWING THE HYBRID CONVERGENT PROCEDURE IN PERSISTENT AND LONGSTANDING PERSISTENT ATRIAL FIBRILLATION: A CONVERGE T	24
PO-01-105 PRECLINICAL EVALUATION OF ACUTE AND CHRONIC CIRCUMFERENTIAL, LINEAR AND FOCAL PULSED FIELD ABLATION LESION SETS CREATED USING A “MAP & ABLATE” SPHERICAL MULTIELECTRODE ARRAY CATHETER	24
PO-634-08 PULSED FIELD ABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION IS SAFE FOR THE ESOPHAGUS	24
PO-636-08 PULSE FIELD ABLATION FOR PULMONARY VEIN ISOLATION: ACUTE RESULTS FROM A MULTICENTRIC REGISTRY	23
CA-527-02 LESION CHARACTERISTICS WITH HIGH POWER SHORT DURATION AND CONVENTIONAL RADIOFREQUENCY ABLATION WITHOUT TEMPERATURE CONTROL	23
PO-637-01 ATRIAL FIBRILLATION ABLATION IN PATIENTS WITH SEVERELY REDUCED EJECTION FRACTION PRIOR TO CONSIDERATION OF PRIMARY PREVENTION ICD IMPLANTATION	23
PO-637-08 A COMPARISON BETWEEN DECELERATION ZONES ON ISOCHRONAL LATE ACTIVATION MAPPING AND SUBSTRATE FOR VENTRICULAR TACHYCARDIA USING CT LATE IODINATED CONTRAST ENHANCEMENT AND WALL THINNING	23
CA-527-03 DOES HIGH POWER - SHORT RADIOFREQUENCY ABLATION PRODUCE WIDER ATRIAL LESIONS ?	23
PO-01-025 EPICARDIAL LEAD PERFORMANCE TRENDS IN PEDIATRICS AND CONGENITAL HEART DISEASE: WHAT STARTS UP, MUST COME DOWN	23
PO-01-023 SIGNIFICANCE OF RENAL FUNCTION CHANGE AFTER CATHETER ABLATION IN NON-PAROXYSMAL ATRIAL FIBRILLATION PATIENTS - ANALYSIS USING CYSTATIN C-BASED EGFR	23
CE-521-03 LONG TERM OUTCOMES OF LEFT CARDIAC SYMPATHETIC DENERVATION FOR LONG QT SYNDROME AND CATHECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA	22
PO-01-051 EARLY PHYSICIAN ARRIVAL TO ELECTROPHYSIOLOGY LABORATORY INCREASES LAB EFFICIENCY BY DECREASING PREPARATION TIME	22
CE-521-01 STELLATE GANGLION INSTRUMENTATION FOR RECORDING AND STIMULATION IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS. PRELIMINARY EXPERIENCE	22
PO-01-047 EVALUATION OF EARLY REMOVAL OF FIGURE-OF-EIGHT SUTURE POST LEFT ATRIAL APPENDAGE CLOSURE DEVICE IMPLANTATION	22
CE-521-02 REPRODUCIBILITY OF CARDIAC GANGLIONATED PLEXUS LOCALISATION USING A NOVEL CURRENT-CONTROLLED HIGH FREQUENCY STIMULATOR	22
CI-523-01 CONDUCTION SYSTEM PACING VERSUS CONVENTIONAL PACING IN PATIENTS UNDERGOING AV NODE ABLATION: NON-RANDOMIZED, ON-TREATMENT COMPARISON	22
CE-520-02 ELECTRO-ANATOMIC REPOLARIZATION MAPPING WITH ORTHOGONAL BIPOLES AND MULTI-ELECTRODE ARRAYS: THE NEXT FRONTIER IN CATHETER TECHNOLOGY	22
PO-02-124 MITOCHONDRIAL GLYCEROL-3-PHOSPHATE DEHYDROGENASE ACTS AT THE CROSSROAD OF METABOLISM REPROGRAMMING IN NON-VALVULAR ATRIAL FIBRILLATION: INDICATION FROM MULTI-OMICS ANALYSIS OF HUMAN AF MYOCA	21
PO-696-01 3D NAVIGATED DELIVERY OF PULSE FIELD ABLATION	21
B-PO05-061 SAFETY OF INTRAOPERATIVE PLACEMENT OF PERMANENT LEADLESS PACEMAKERS COMPARED TO TEMPORARY EPICARDIAL WIRE PLACEMENT	21
CA-529-04 EFFECT OF PULMONARY VEIN ISOLATION ON ELECTROGRAPHIC FLOW-IDENTIFIED EXTRA-PULMONARY VEIN SOURCES PRE- V. POST-ABLATION	21
HF-564-01 READMISSION OUTCOMES IN PATIENTS WITH CARDIAC SARCOIDOSIS	21
PO-696-05 RISK OF VENOUS THROMBOSIS AND THROMBOEMBOLISM IN PATIENTS UNDERGOING RIGHT SIDED ABLATION PROCEDURES WITH OR WITHOUT SYSTEMIC ANTICOAGULATION	21
PO-694-06 CONVOLUTIONAL NEURAL NETWORKS TO IDENTIFY DRIVERS IN PERSISTENT ATRIAL FIBRILLATION PATIENTS	21
PO-02-145 SPATIAL TRANSCRIPTOMICS IN THE HUMAN PULMONARY VEIN SLEEVE	21
CA-534-03 INVESTIGATING PULSED FIELD (PFA) VS RADIOFREQUENCY ABLATION (RFA) LESION CHARACTERISTICS IN AN IN VIVO HEALTHY PORCINE LEFT VENTRICLE (LV) USING 3D LGE AND NATIVE T1W MAGNETIC RESONANCE IMAG	20
B-PO05-083 THE CORRELATION BETWEEN LEFT ATRIAL WALL HYPERTROPHY AND HIGH UNIPOLAR VOLTAGES ALONG THE ABLATION LINE AND THEIR IMPACT ON ATRIAL FIBRILLATION RECURRENCE IN PATIENTS AFTER PULMONARY VEIN I	20
B-PO05-079 REPRODUCIBILITY OF CONDUCTION VELOCITY MAPS USING OMNIPOLAR TRAVELING WAVES AND LOCAL ACTIVATION TIMING	20
B-PO05-086 STRUCTURAL AND TISSUE REMODELING OF THE LEFT ATRIUM AND LEFT ATRIAL APPENDAGE AFTER ATRIAL FIBRILLATION ABLATION	20
HP-574-04 ASSOCIATIONS BETWEEN OBESITY PARAMETERS AND THE RISK OF INCIDENT ATRIAL FIBRILLATION AND ISCHEMIC STROKE IN DIFFERENT AGE GROUPS: A NATIONWIDE POPULATION-BASED STUDY	20
B-PO05-078 THE NOVEL USE OF OMNIPOLAR ELECTROGRAMS TO PERFORM VOLTAGE MAPPING IN PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION	20
B-PO05-081 SIMULTANEOUS ULTRA-HIGH RESOLUTION OPTICAL MAPPING AND CATHETER MAPPING IN A LANGENDORFF-PERFUSED SWINE HEART MODEL TO IDENTIFY ATRIAL FIBRILLATION ROTORS BY CATHETER MAPPING	20
HP-574-02 PROPORTION OF WOMEN AND REPORTING OF OUTCOMES BY SEX IN CONTEMPORARY CLINICAL TRIALS OF ATRIAL FIBRILLATION	20
B-PO05-077 VISUALIZATION OF ELECTROGRAPHIC FLOW FIELDS OF INCREASING COMPLEXITY DURING SINUS RHYTHM, PACING AND PERSISTENT AF	20
CA-534-04 UNDERSTANDING THE RISK OF CORONARY ARTERY SPASM DURING PULSED FIELD ABLATION	19
B-PO05-102 THE CONVERGENT PROCEDURE: TWO-YEAR OUTCOMES AND PREDICTORS OF SUCCESS	19
B-PO05-089 PERSISTENT ATRIAL FIBRILLATION REORGANIZATION DURING ABLATION IS ASSOCIATED WITH ORGANIZED RECURRENCE AT FOLLOW-UP	19
PO-01-168 PREVALENCE OF ATRIAL FIBRILLATION IN PATIENTS WITH PRIMARY AUTONOMIC FAILURE	19
HF-567-04 VENTRICULAR TACHYCARDIA PRIOR TO CFLVAD IMPLANTATION DOES NOT IMPACT SURVIVAL WHEN STRATIFIED BY VAD TYPE	19
BS-526-02 ROLE OF THE SUCCINATE PATHWAY IN THE ELECTROPHYSIOLOGICAL PROPERTIES OF RIGHT ATRIA IN A PERSISTENT ATRIAL FIBRILLATION SHEEP MODEL	19
PO-01-140 ATRIAL FIBRILLATION AND SEPTIC SHOCK: A FIVE-YEAR RETROSPECTIVE OBSERVATIONAL STUDY OF ANTICOAGULATION USAGE, BLEEDING AND STROKE RATES	19
CA-535-01 THE RANDOMIZED POWER PULSE TRIAL: SAFETY AND INTRAPROCEDURAL PULMONARY VEIN RECONNECTION USING VERY HIGH POWER SHORT DURATION ABLATION (70W) VS. STANDARD ABLATION IN PAROXYSMAL AF	19
B-PO04-141 LEFT ATRIAL APPENDAGE OCCLUSION VERSUS ORAL ANTICOAGULATION AS PRIMARY STRATEGIES TO PREVENT LAA THROMBUS AND STROKE FOLLOWING LEFT ATRIAL APPENDAGE ELECTRICAL ISOLATION: APROPENSITY SCORE-	18
MP-453087-3 REMOVAL OF A CHRONICALLY-IMPLANTED MICRA LEADLESS VENTRICULAR – SINGLE CENTER EXPERIENCE	18
PO-455617-19 INFLUENCE OF POSTERIOR WALL ACTIVITY ON AF ABLATION OUTCOMES: A CAPLA SUBSTUDY	18
B-PO04-135 PERCUTANEOUS AND THORACOTOMY BASED SINUS NODE ABLATION USING NANOSECOND PULSED ELECTRIC FIELDS	18
PO-455617-7 CHRONIC SYMPATHETIC REMODELING IN HEART FAILURE IMPACTS WHOLE-HEART CAMP SIGNALING AND ARRHYTHMOGENESIS.	18
PE-568-03 ASSOCIATION OF CENTER ABLATION VOLUME AND PROCEDURAL OUTCOMES IN CHILDREN: AN ANALYSIS OF THE IMPACT REGISTRY	18
MP-453092-3 HEALTH-RELATED QUALITY OF LIFE AND WEARABLE-MEASURED DIGITAL BIOMAKER IN AN ICD POPULATION: A SUB-STUDY OF THE ONGOING SAFEHEART-STUDY	17
DH-575-01 MACHINE LEARNING-ENABLED MULTIMODAL FUSION OF INTRA-ATRIAL AND BODY SURFACE SIGNALS IN PREDICTION OF ATRIAL FIBRILLATION ABLATION OUTCOMES	17
B-PO04-176 THE ARTIFICIAL INTELLIGENCE-ENABLED ENDOCARDIAL SIGNAL PREDICTION OF TERMINATION SITE DURING CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION	17
PO-02-140 CENTRAL RETINAL ARTERY OCCLUSION: A SYSTEMATIC REVIEW AND META-ANALYSIS FOR THE RISK OF NEW-ONSET ATRIAL FIBRILLATION AND STROKE	17
B-PO04-158 TROPONIN ELEVATION DURING EPISODES OF SUPRAVENTRICULAR TACHYCARDIA	17
MP-453081-7 A COMPARISON OF LEFT CIRCUMFLEX CORONARY VASOSPASM BETWEEN RADIOFREQUENCY ABLATION AND PULSED FIELD ABLATION AT THE MITRAL ISTHMUS	17
AB-452666-2 CATHETER ABLATION OF ATRIAL FIBRILLATION AND ATRIAL TACHYCARDIA IN PATIENTS WITH PULMONARY HYPERTENSION: A RANDOMISED STUDY	17
PO-02-156 THE RISE OF LEFT BUNDLE BRANCH AREA "PACE AND ABLATE"; AV NODAL ABLATION OUTCOMES, WHERE ARE WE NOW?	17
MP-453081-3 PHENOTYPES OF PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION AND RISK OF ARRHYTHMIA RECURRENCE - A DECAAF II SUBANALYSIS	17
PO-690-03 ATRIAL ELECTROMECHANICAL DISSOCIATION AS A NOVEL NON-INVASIVE PARAMETER OF EARLY REMODELING PROGRESSION DURING ATRIAL FIBRILLATION	17
PO-02-139 ASSESSING OUTCOMES IN PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION AND ATRIAL FIBRILLATION: A POPULATION-BASED STUDY	17
PO-690-02 ABLATION SCAR ARRHYTHMOGENICITY CAN BE PREDICTED BY AN EXPLAINABLE MACHINE LEARNING (ML) CLASSIFIER: PROOF-OF-CONCEPT FROM COMPUTATIONAL SIMULATIONS	17
B-PO04-181 AN EVALUATION OF LEFT VENTRICULAR REVERSE REMODELING IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK AND QRS DURATION LESS THAN 150MS	16
PO-02-170 EFFECT OF LOW DOSE COLCHICINE USE ON RECURRENCE OF ATRIAL FIBRILLATION AFTER CATHETER ABLATION	16
PO-02-171 CLINICAL, HEALTHCARE UTILIZATION AND ECONOMIC IMPACT OF SAME DAY DISCHARGE FOLLOWING ATRIAL FIBRILLATION ABLATION	16
MP-453088-9 THE SPATIAL VENTRICULAR GRADIENT IS ASSOCIATED WITH CARDIAC MAGNETIC RESONANCE MARKERS OF OF DIFFUSE MYOCARDIAL FIBROSIS	16
CA-530-03 TAILORED ABLATION INDEX BASED ON LEFT ATRIAL WALL THICKNESS ASSESSED BY COMPUTED TOMOGRAPHY FOR PULMONARY VEIN ISOLATION IN PATIENTS WITH ATRIAL FIBRILLATION	16
CE-538-01 TRANSCATHETER LEAK OCCLUSION WITH ENDOVASCULAR COILS FOLLOWING LEFT ATRIAL APPENDAGE CLOSURE: PROCEDURAL SUCCESS AND OUTCOMES BEFORE AND AFTER LEAK CLOSURE	16
B-PO04-194 PEDIATRIC T-WAVE MEMORY AFTER ACCESSORY PATHWAY ABLATION IN WOLFF-PARKINSON-WHITE SYNDROME	16
PO-691-04 SATURATED FATTY ACIDS DIFFERENTIALLY MODULATE ION CHANNEL AND STRUCTURAL REMODELING IN MATURE IPSC-DERIVED ATRIAL CARDIOMYOCYTES LEADING TO OBESITY-INDUCED ATRIAL FIBRILLATION	16
MP-453089-5 CLINICAL BENEFITS OF EARLY LEFT BUNDLE BRANCH PACING IN HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION AND LEFT BUNDLE BRANCH BLOCK	16
PO-02-164 VALUE OF CARDIONEUROABLATION WITH VAGAL DENERVATION CONFIRMED BY VAGUS NERVE STIMULATION ON PULMONARY VEIN ISOLATION FOR ATRIAL FIBRILLATION CATHETER ABLATION	16
PO-02-167 IMPACT OF OBESITY ON QUALITY OF LIFE AND CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PRIMO PULMONARY VEIN ISOLATION	16
B-PO04-192 RISK FACTORS FOR NON-RESPONSE TO BIVENTRICULAR PACING IN L-LOOPED TRANSPOSITION OF THE GREAT ARTERIES AFTER THE DOUBLE SWITCH OPERATION	16

CE-538-03 INCIDENCE, PREDICTORS, AND CLINICAL OUTCOMES OF PERI-DEVICE LEAK IN SUBJECTS UNDERGOING TRANSCATHETER LEFT ATRIAL APPENDAGE CLOSURE IN THE AMULET IDE TRIAL	16
MP-453092-7 THE IMPACT OF ELECTROANATOMICAL MAPPING AND VT SUBSTRATE ABLATION ON PRIMARY AND SECONDARY PREVENTION ICD INDICATION IN PATIENTS WITH REPAIRED TETRALOGY OF FALLOT	16
B-PO04-216 BI-ATRIAL PACING VIA Y-ADAPTOR USING THE VEIN OF MARSHALL	15
PO-02-199 A NOVEL FINDING: SERUM MICRORNA-122 CORRELATES WITH LEFT ATRIAL SUBSTRATE IN PATIENTS WITH ATRIAL FIBRILLATION	15
PO-692-05 MACRO COMPLICATIONS WITH MICRA — PROCEDURAL COMPLICATIONS OF LEADLESS VERSUS TRANSVENOUS PACEMAKERS USING THE NATIONWIDE READMISSION DATABASE (NRD)	15
CI-525-03 DEVICE-TO-DEVICE COMMUNICATION FOR A NOVEL DUAL-CHAMBER LEADLESS PACEMAKER SYSTEM: RELIABILITY OF MAINTAINING ATRIOVENTRICULAR SYNCHRONY IN AN OVINE MODEL OF AV CONDUCTION BLOCK	15
PO-02-229 AUTOMATED LOCALIZATION OF ATRIAL ECTOPIC BEATS USING 12-LEAD ECG MEAN SPATIO-TEMPORAL VECTOR POSITION: IMPORTANCE OF INCORPORATING PATIENT-SPECIFIC ANATOMIC MODELS	15
PO-693-01 CONDUCTION SYSTEM PACING GUIDED BY THE SELECTRA 3D DELIVERY SHEATH: ACUTE AND MEDIUM TERM TECHNICAL OUTCOMES	15
PO-01-126 SEXUAL DIMORPHISM AND CARDIAC ARRHYTHMIAS IN A MOUSE MODEL OF FRIEDREICH'S ATAXIA: WHAT DO WE KNOW?	15
PO-02-202 CORONARY SINUS PRESSURE FOLLOWING RETROGRADE CARDIOPLEGIA PREDICTS POSTOPERATIVE ATRIAL FIBRILLATION	15
PO-01-145 DYNAMIC UTR COMPOSITION IMPACTS RNA BINDING PROTEIN COMPLEXING TO CONTROL TRANSLATION AND LIMIT CARDIAC GAP JUNCTION FORMATION DURING STRESS	15
B-PO05-012 PREDICTING ATRIAL FIBRILLATION RECURRENCE BY COMBINING POPULATION DATA & PATIENT-SPECIFIC MODELING	15
HF-566-02 PREDICTED RISK OF VENTRICULAR ARRHYTHMIA IN INDIVIDUALS WITH DESMOSOME GENE VARIANTS IDENTIFIED VIA POPULATION GENOMIC SCREENING	15
CI-452769-4 CONTEMPORARY IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR BENEFIT: A REAL-WORLD ANALYSIS	15
B-PO04-217 CARDIAC RESYNCHRONISATION THERAPY IN A HEART TRANSPLANT RECIPIENT: A CASE REPORT	15
BS-514-04 ADENOVIRUS INCREASES ARRHYTHMIA SUSCEPTIBILITY DURING ACUTE CARDIAC INFECTION	15
PO-02-224 CONDUCTION VELOCITIES DETERMINED BY NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING PREDICT ARRHYTHMIA-FREE SURVIVAL AFTER PULMONARY VEIN ISOLATION	15
B-PO05-010 REMOVING THE VENTRICULAR FAR FIELD FROM UNIPOLAR ATRIAL ELECTROGRAMS IN A CLINICALLY FEASIBLE SETUP WITH A PHYSICALLY MOTIVATED MODEL YIELDS HIGH QUALITY RESULTS	15
B-PO05-014 A RETROSPECTIVE STUDY OF SEASONAL VARIABILITY OF CARDIAC ELECTROPHYSIOLOGY IN THE RABBIT HEART	15
B-PO05-006 USING MACHINE LEARNING TO IDENTIFY PATIENTS LIKELY TO REQUIRE REPEAT CATHETER ABLATION FOR ATRIAL FIBRILLATION: INSIGHTS FROM THE UC SAN DIEGO AF ABLATION REGISTRY	15
EN-580-03 SUPPRESSION AND REPLACEMENT GENE THERAPY FOR KCNH2-MEDIATED ARRHYTHMIAS	14
TOC	14
PO-01-176 ASSOCIATION BETWEEN LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND SUDDEN CARDIAC ARREST IN PEOPLE WITH DIABETES MELLITUS	14
PE-565-03 NON-INVASIVE IDENTIFICATION OF SLOW CONDUCTING ANATOMICAL ISTHMUSES IN PATIENTS WITH TETRALOGY OF FALLOT BY 3-DIMENSIONAL LATE GADOLINIUM ENHANCEMENT CARDIOVASCULAR MAGNETIC RESONANCE IMAGIN	14
B-PO05-039 MET SCORE IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION	14
B-PO05-037 ELECTROCARDIOGRAPHIC CHARACTERISTICS WITH LEFT BUNDLE BRANCH AREA PACING: A SINGLE CENTER PROSPECTIVE STUDY	14
PO-01-174 GENETIC MODULATION OF PROTEIN O-GLCNACYLATION AFFECTS ATRIAL FIBRILLATION SUSCEPTIBILITY	14
B-PO05-027 GENOME SEQUENCING IN A GENETICALLY ELUSIVE MULTI-GENERATIONAL LONG QT SYNDROME PEDIGREE IDENTIFIES A NOVEL PATHOGENIC CAUSE	14
HP-573-04 VARIATION IN HOSPITAL USE OF CRT-D AMONG ELIGIBLE PATIENTS AND ASSOCIATION WITH CLINICAL OUTCOMES	14
BS-515-01 NON-CODING DELETION INDUCES 3D CHROMATIN REMODELLING AND PITX2 EXPRESSION DYSREGULATION ASSOCIATED WITH A SYNDROMIC CARDIAC DISORDER	14
PO-01-182 CONDUCTION SYSTEM PACING REMAINS EFFECTIVE IN PATIENTS WITH NON-CONDUCTIVE SEPTAL SCAR BUT SURVIVING PURKINJE	14
B-PO05-042 REDUCING CLINICAL REVIEW BURDEN OF INSERTABLE CARDIAC MONITORS IN PATIENTS WITH FREQUENT ARRHYTHMIA DETECTIONS	14
PO-01-180 MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION-INDUCED ATRIAL FIBRILLATION IN THE RIGHT HEART: INSIGHTS FROM MULTI-SCALE MODELS OF THE HUMAN ATRIA	14
CI-545-03 TRANSVENOUS LEAD EXTRACTION FOR THE MANAGEMENT OF TRICUSPID REGURGITATION	14
PE-565-01 PROGRAMMED VENTRICULAR STIMULATION AS AN ADDITIONAL PRIMARY PREVENTION RISK STRATIFICATION TOOL IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY: A MULTINATIONAL STUDY	14
B-PO05-034 EFFECT OF PROGRAMMED AV DELAYS ON RIGHT BUNDLE BRANCH BLOCK IN NON-SELECTIVE HIS BUNDLE PACING	14
PO-617-07 MODELS OF SEX-DEPENDENT EPIGENETIC TRANSCRIPTIONAL CONTROL OF CARDIAC ELECTROPHYSIOLOGY IN THE ADULT HUMAN HEART BASED ON THE GTEX DATABASE	13
B-PO05-059 LEFT ATRIAL APPENDAGE OCCLUSION (LAAO) USING WATCHMAN DEVICE IN END STAGE RENAL DISEASE: ANALYSIS FROM NATIONAL INPATIENT SAMPLE	13
PO-618-04 LONGEVITY OF MODEL-3501 SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR LEAD IN CLINICAL PRACTICE	13
PO-619-07 CHEST WALL ADIPOSE TISSUE EXCISIONAL BIOPSY DURING PACEMAKER OR DEFIBRILLATOR IMPLANTATION: FIRST REPORT OF A NEW TECHNIQUE TO DIAGNOSE AND SUBTYPE AMYLOIDOSIS	13
B-PO05-213 REVERSAL OF HYPOCALCEMIA-INDUCED DILATED CARDIOMYOPATHY TREATED WITH CRT-D	13
PO-01-085 ATRIAL AND VENTRICULAR ARRHYTHMIAS IN A PATIENT WITH TUBEROUS SCLEROSIS	13
PO-619-01 SAFETY AND FEASIBILITY OF LEADLESS PACEMAKER IMPLANTATION VIA A LEFT FEMORAL VEIN APPROACH: EXPERIENCE WITH THE MICRA TRANSCATHETER PACEMAKER	13
PO-01-112 FLUOROLESS TRANSBAFFLE MAPPING AND ABLATION OF ATYPICAL ATRIAL FLUTTER FOLLOWING ATRIAL SWITCH PROCEDURE	13
B-PO05-190 ATHLETES WITH SUDDEN CARDIAC DEATH-PREDISPOSING GENETIC HEART DISEASE: WINNING THE ‘RETURN-TO-PLAY’ GAME	13
PO-617-02 A HIDDEN STRATIFICATION PROBLEM IN NEURAL ECG ANALYSIS	13
PO-617-05 PREDICTING ABLATION RESPONSE IN PERSISTENT ATRIAL FIBRILLATION BY MACHINE LEARNING OF GLOBAL ATRIAL ELECTROGRAM PATTERNS	13
PO-618-08 IMPACT OF LEFT BUNDLE AREA PACING ON QRS DURATION IN PATIENTS WITH PREEXISTING RIGHT BUNDLE BRANCH BLOCK: INSIGHT INTO MECHANISM OF QRS SHORTENING	13
PO-01-110 ATRIAL TORSADES DE POINTES POST COVID MYOCARDITIS	13
PO-619-03 OPTIMIZATION OF LONG PR INTERVALS WITH HIS BUNDLE PACING	13
PO-01-234 DETECTING RISK OF HIGH HEALTH CARE UTILIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: A SUPERVISED MACHINE LEARNING APPROACH	13
B-PO05-193 UNIQUE CIRCADIAN VARIATION OF SUDDEN CARDIAC DEATH IN THE YOUNG	13
B-PO05-186 IMPACT OF GUIDELINE-BASED MEDICAL THERAPY ON VENTRICULAR ARRHYTHMIAS AND MORTALITY AMONG HEART FAILURE PATIENTS IMPLANTED WITH A PRIMARY PREVENTION ICD/CRTD	13
B-PO05-050 OUTCOMES OF HIS BUNDLE VS LEFT BUNDLE BRANCH PACING FOLLOWING AV NODE ABLATION	13
B-PO05-199 DIFFERENCES IN STROKE OR SYSTEMIC THROMBOEMBOLISM READMISSIONS AFTER HOSPITALIZATION FOR ATRIAL FIBRILLATION OR ATRIAL FLUTTER	13
PO-620-06 VALIDATION OF RISK SCORE PREDICTING NEED FOR PACEMAKER IMPLANT AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT	13
PO-618-06 REMOTE PROGRAMMING OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES: MULTI-CENTRIC EVALUATION OF A CUSTOM MULTIVENDOR SOLUTION	13
PO-619-05 DYNAMIC CHANGES IN HIS BUNDLE STRENGTH DURATION CURVES FAVOR SELECTIVE PACING STRATEGIES	13
PO-623-05 TUBERCULO SARCOIDOSIS OF THE HEART: DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS	12
PO-622-03 REDUCING DIVERSE TYPES OF NOISE IN ELECTROPHYSIOLOGICAL SIGNALS USING MACHINE LEARNED AUTOENCODERS	12
PO-622-05 USE OF LOCAL ACTIVATION TIME HISTOGRAM ALGORITHM FOR DETERMINATION OF ARRHYTHMIA MECHANISM AND TO GUIDE ABLATION STRATEGY	12
PO-624-04 ADVANCED TECHNIQUES TO MAXIMIZE TISSUE REACH OF CORONARY VENOUS ETHANOL IN ABLATION-REFRACTORY VENTRICULAR ARRHYTHMIAS	12
PO-624-07 ADVERSE EVENTS OF PENTARAY CATHETER VERSUS HIGH DENSITY GRID CATHETER : A REVIEW OF MAUDE DATABASE	12
PO-01-026 STEREOTACTIC CARDIAC RADIOTHERAPY FOR RECURRENT VENTRICULAR TACHYCARDIA IN PRESENCE OF WIRELESS LEFT VENTRICULAR ENDOCARDIAL STIMULATION SYSTEM	12
B-PO05-218 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DELIVERING INAPPROPRIATE THERAPY DUE TO SUBCUTANEOUS AIR	12
PO-01-081 EPICARDIAL PHRENIC NERVE DEFLECTION DURING SINUS NODE MODIFICATION	12
Author Index	12
PO-01-045 INJURY TO THE LEFT INTERNAL THORACIC ARTERY DURING PERCUTANEOUS EPICARDIAL ACCESS FOR CATHETER ABLATION: PREVENTION AND MANAGEMENT	12
PO-01-027 A MULTIPOLAR ELECTRODE MAPPING CATHETER AND A MECHANICAL VALVE: TO USE OR NOT TO USE?	12
PO-626-08 LEFT ATRIAL APPENDAGE OCCLUSION WITH LEFT ATRIAL FOUR DIMENSIONAL INTRACARDIAC ECHOCARDIOGRAPHY	12
B-PO05-220 SUCCESSFUL ABLATION OF INCESSANT UPPER SEPTAL VT IN A PATIENT WITH CARDIOGENIC SHOCK AND COVID	12
PO-621-06 SHORTER LEARNING CURVE OF LEFT BUNDLE PACING COMPARED TO HIS BUNDLE PACING	12
B-IN01-08 LOCAL ABNORMAL VENTRICULAR ACTIVITY REVEALS CONDUCTION PROPERTY DIFFERENT TO SYSTOLIC ACTIVATION DIRECTION USING OMNIPOLAR METHODOLOGY: LAVA FLOW	12
PO-01-075 TRANSTHORACIC ECHOCARDIOGRAPHY FOR EARLIER DIAGNOSIS OF ATRIOESOPHAGEAL FISTULA AFTER ABLATION FOR ATRIAL FIBRILLATION	12
Young Investigator Award Competition Sub-Committee	12
PO-01-028 LEAD HELIX FAILS TO RETRACT DURING LEFT BUNDLE BRANCH AREA PACING IMPLANT	12
PO-01-029 TRANSCATHETER LEFT ATRIAL APPENDAGE OCCLUSION IN A PATIENT WITH COR TRIATRIATUM SINISTER	12
CE-543-04 INTER-ATRIAL BLOCK IDENTIFIES PATIENTS WITH LOW CHA2DS2-VASC SCORE BUT HIGH STROKE RISK	11
PC-578-04 TRANSHEPATIC PERMANENT PACEMAKER LEAD PLACEMENT	11
PO-632-07 EFFECTIVENESS OF THE WEARABLE CARDIOVERTER DEFIBRILLATOR IN PATIENTS WITH COVID-19	11
PO-01-091 VEIN OF MARSHALL ETHANOL ABLATION AND LATERAL MITRAL ISTHMUS LINE TO IMPROVE EFFICACY OF PERSISTENT AF ABLATION	11
PO-01-072 INTER-PROCEDURAL REPRODUCIBILITY OF ELECTROGRAPHIC FLOW MAPPING BETWEEN PROCEDURES SEPARATED BY 3 MONTHS OR LONGER	11
B-PO05-137 ARRHYTHMIC BURDEN AND THEIR PROGNOSTIC EFFECT ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS	11
CE-543-03 EARLY RHYTHM CONTROL IN PATIENTS WITH INCIDENT ATRIAL FIBRILLATION WHO HAD A PRIOR HISTORY OF STROKE: A NATIONWIDE POPULATION-BASED COHORT STUDY	11
AP-519-01 A MULTIDISCIPLINARY APPROACH TO SAME DAY DISCHARGE OF PATIENTS POST ATRIAL FIBRILLATION ABLATION	11
PO-632-06 REAL-TIME EX-VIVO RADIOTHERAPY IMPACTS ON PACEMAKER FUNCTION ARE MINIMAL	11
BS-516-01 A NOVEL COMPUTATIONAL-AI FRAMEWORK TO DETECT SITES OF ORIGINS OF SCAR-RELATED VENTRICULAR TACHYCARDIA FROM IMPLANTED DEVICE ELECTROGRAMS	11
PO-631-08 REAL-TIME INTERACTIVE 3D SIMULATION OF TEMPORARY CARDIAC PACING	11
PO-01-088 SUPPRESSION OF SKIN SYMPATHETIC NERVE ACTIVITY AFTER VEIN OF MARSHALL ETHANOL INFUSION	11
B-PO05-120 A NOVEL NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING MAPPING IS A USEFUL TOOL TO PREDICT PREMATURE VENTRICULAR COMPLEXES LOCALIZATION BEFORE CATHETER ABLATION PROCEDURE	11
B-PO05-118 RIGHT VENTRICULAR LONGITUDINAL STRAIN ON CMR PREDICTS VENTRICULAR ARRHYTHMIC AND MORTALITY IN CARDIAC SARCOIDOSIS	11
PO-633-01 THE EFFECT OF DEFIBRILLATOR ON MORTALITY IN NON-ISCHEMIC CARDIOMYOPATHY WITH RESYNCHRONIZATION THERAPY	11
PO-632-04 PATTERNS OF DEVICE-RELATED INFECTION IN DE NOVO TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR MEDICARE PATIENTS WITH UNDERLYING RENAL DISEASE	11
PO-630-01 FAM13B AND RS1717131 ARE THE LIKELY GENE AND SNP RESPONSIBLE FOR THE 5Q31 ATRIAL FIBRILLATION SUSCEPTIBILITY LOCUS	11
PO-01-194 A COMPARISON OF CLINICAL OUTCOMES FOR THREE DIFFERENT MODALITIES USED FOR PULMONARY VEIN ISOLATION IN PATIENTS WITH ATRIAL FIBRILLATION	11